APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over the Counter (OTC) Drugs & Dietary Supplements

Compare research editions
View pricing & licenses

Selected research

Industry Research

Over the Counter (OTC) Drugs & Dietary Supplements Industry Research Report 2026

20 December 2025139 pages

Choose your research edition.

Industry ResearchOver the Counter (OTC) Drugs & Dietary Supplements Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Over the Counter (OTC) Drugs & Dietary Supplements Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Over the Counter (OTC) Drugs & Dietary Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Over the Counter (OTC) Drugs & Dietary Supplements market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Over the Counter (OTC) Drugs & Dietary Supplements market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Over the Counter (OTC) Drugs & Dietary Supplements market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Over the Counter (OTC) Drugs & Dietary Supplements include Sanofi S.A, Johnson & Johnson, Novartis International AG, Merck & Co., Inc., Roche Holding AG, Pfizer Inc., GlaxoSmithKline plc., Bayer Healthcare AG and AbbVie Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Over the Counter (OTC) Drugs & Dietary Supplements market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Over the Counter (OTC) Drugs & Dietary Supplements.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Over the Counter (OTC) Drugs & Dietary Supplements Market by Company

Sanofi S.A

Johnson & Johnson

Novartis International AG

Merck & Co., Inc.

Roche Holding AG

Pfizer Inc.

GlaxoSmithKline plc.

Bayer Healthcare AG

AbbVie Inc.

AstraZeneca plc.

The Colgate-Palmolive Company

Reckitt Benckiser Plc.

Gilead Sciences

Bausch & Lomb

Alliance Healthcare

Allergan, Plc.

Alkalon A/S

Alfresa Pharma Corporation

Alcon Inc.

Alacer Corp.

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Type

Cough, Cold, and Flu Products

Mineral Supplements

Dermatological Products

Vitamin Supplements

Ophthalmic Products

Analgesic & Pain Relievers

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Application

Retail Pharmacies

Online Pharmacy

Hospital Pharmacies

Others

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over the Counter (OTC) Drugs & Dietary Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over the Counter (OTC) Drugs & Dietary Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over the Counter (OTC) Drugs & Dietary Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Over the Counter (OTC) Drugs & Dietary Supplements companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2021-2026) Table 7. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2027-2032) Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2021-2026) Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2027-2032) Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2021-2026) Table 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2027-2032) Table 18. Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends Table 19. Over the Counter (OTC) Drugs & Dietary Supplements Industry Drivers Table 20. Over the Counter (OTC) Drugs & Dietary Supplements Industry Opportunities and Challenges Table 21. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints Table 22. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2021-2026) Table 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Over the Counter (OTC) Drugs & Dietary Supplements, Headquarters and Area Served Table 26. Global Over the Counter (OTC) Drugs & Dietary Supplements Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032) & (US$ Million) Table 45. Sanofi S.A Company Information Table 46. Sanofi S.A Business Overview Table 47. Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 48. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 49. Sanofi S.A Recent Developments Table 50. Johnson & Johnson Company Information Table 51. Johnson & Johnson Business Overview Table 52. Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 53. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 54. Johnson & Johnson Recent Developments Table 55. Novartis International AG Company Information Table 56. Novartis International AG Business Overview Table 57. Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 58. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 59. Novartis International AG Recent Developments Table 60. Merck & Co., Inc. Company Information Table 61. Merck & Co., Inc. Business Overview Table 62. Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 63. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 64. Merck & Co., Inc. Recent Developments Table 65. Roche Holding AG Company Information Table 66. Roche Holding AG Business Overview Table 67. Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 68. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 69. Roche Holding AG Recent Developments Table 70. Pfizer Inc. Company Information Table 71. Pfizer Inc. Business Overview Table 72. Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 73. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 74. Pfizer Inc. Recent Developments Table 75. GlaxoSmithKline plc. Company Information Table 76. GlaxoSmithKline plc. Business Overview Table 77. GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 78. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 79. GlaxoSmithKline plc. Recent Developments Table 80. Bayer Healthcare AG Company Information Table 81. Bayer Healthcare AG Business Overview Table 82. Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 83. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 84. Bayer Healthcare AG Recent Developments Table 85. AbbVie Inc. Company Information Table 86. AbbVie Inc. Business Overview Table 87. AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 88. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 89. AbbVie Inc. Recent Developments Table 90. AstraZeneca plc. Company Information Table 91. AstraZeneca plc. Business Overview Table 92. AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 93. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 94. AstraZeneca plc. Recent Developments Table 95. The Colgate-Palmolive Company Company Information Table 96. The Colgate-Palmolive Company Business Overview Table 97. The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 98. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 99. The Colgate-Palmolive Company Recent Developments Table 100. Reckitt Benckiser Plc. Company Information Table 101. Reckitt Benckiser Plc. Business Overview Table 102. Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 103. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 104. Reckitt Benckiser Plc. Recent Developments Table 105. Gilead Sciences Company Information Table 106. Gilead Sciences Business Overview Table 107. Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 108. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 109. Gilead Sciences Recent Developments Table 110. Bausch & Lomb Company Information Table 111. Bausch & Lomb Business Overview Table 112. Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 113. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 114. Bausch & Lomb Recent Developments Table 115. Alliance Healthcare Company Information Table 116. Alliance Healthcare Business Overview Table 117. Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 118. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 119. Alliance Healthcare Recent Developments Table 120. Allergan, Plc. Company Information Table 121. Allergan, Plc. Business Overview Table 122. Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 123. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 124. Allergan, Plc. Recent Developments Table 125. Alkalon A/S Company Information Table 126. Alkalon A/S Business Overview Table 127. Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 128. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 129. Alkalon A/S Recent Developments Table 130. Alfresa Pharma Corporation Company Information Table 131. Alfresa Pharma Corporation Business Overview Table 132. Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 133. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 134. Alfresa Pharma Corporation Recent Developments Table 135. Alcon Inc. Company Information Table 136. Alcon Inc. Business Overview Table 137. Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 138. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 139. Alcon Inc. Recent Developments Table 140. Alacer Corp. Company Information Table 141. Alacer Corp. Business Overview Table 142. Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) & (US$ Million) Table 143. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 144. Alacer Corp. Recent Developments Table 145. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Over the Counter (OTC) Drugs & Dietary Supplements Product Image Figure 5. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type: 2025 VS 2032 Figure 7. Cough, Cold, and Flu Products Product Figure 8. Mineral Supplements Product Figure 9. Dermatological Products Product Figure 10. Vitamin Supplements Product Figure 11. Ophthalmic Products Product Figure 12. Analgesic & Pain Relievers Product Figure 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2025 VS 2032 Figure 15. Retail Pharmacies Product Figure 16. Online Pharmacy Product Figure 17. Hospital Pharmacies Product Figure 18. Others Product Figure 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2025 VS 2032 Figure 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players in 2025 Figure 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Established Date Figure 24. Global Top 5 and 10 Over the Counter (OTC) Drugs & Dietary Supplements Players Market Share by Revenue in 2025 Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 28. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 31. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 33. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Spain Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Netherlands Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 43. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. India Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 48. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. China Taiwan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. South America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 53. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Chile Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Colombia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 57. Peru Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 58. Sanofi S.A Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 59. Johnson & Johnson Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 60. Novartis International AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 61. Merck & Co., Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 62. Roche Holding AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 63. Pfizer Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 64. GlaxoSmithKline plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 65. Bayer Healthcare AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 66. AbbVie Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 67. AstraZeneca plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 68. The Colgate-Palmolive Company Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 69. Reckitt Benckiser Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 70. Gilead Sciences Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 71. Bausch & Lomb Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 72. Alliance Healthcare Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 73. Allergan, Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 74. Alkalon A/S Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 75. Alfresa Pharma Corporation Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 76. Alcon Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026) Figure 77. Alacer Corp. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)

Scope & coverage.

Types
  • Cough, Cold, and Flu Products
  • Mineral Supplements
  • Dermatological Products
  • Vitamin Supplements
  • Ophthalmic Products
  • Analgesic & Pain Relievers
Applications
  • Retail Pharmacies
  • Online Pharmacy
  • Hospital Pharmacies
  • Others
Companies covered
  • Sanofi S.A
  • Johnson & Johnson
  • Novartis International AG
  • Merck & Co., Inc.
  • Roche Holding AG
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Bayer Healthcare AG
  • AbbVie Inc.
  • AstraZeneca plc.
  • The Colgate-Palmolive Company
  • Reckitt Benckiser Plc.
  • Gilead Sciences
  • Bausch & Lomb
  • Alliance Healthcare
  • Allergan, Plc.
  • Alkalon A/S
  • Alfresa Pharma Corporation
  • Alcon Inc.
  • Alacer Corp.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Over the Counter (OTC) Drugs & Dietary Supplements by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Cough, Cold, and Flu Products
  5. 2.2.3 Mineral Supplements
  6. 2.2.4 Dermatological Products
  7. 2.2.5 Vitamin Supplements
  8. 2.2.6 Ophthalmic Products
  9. 2.2.7 Analgesic & Pain Relievers
  10. 2.3 Over the Counter (OTC) Drugs & Dietary Supplements by Application
  11. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.3.2 Retail Pharmacies
  13. 2.3.3 Online Pharmacy
  14. 2.3.4 Hospital Pharmacies
  15. 2.3.5 Others
  16. 2.4 Assumptions and Limitations
3 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
  1. 3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Type (2021-2026)
  2. 3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2027-2032)
4 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application
  1. 4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Application (2021-2026)
  2. 4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2021-2032)
  2. 5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region
  3. 5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Region (2021-2026)
  5. 5.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2027-2032)
  6. 5.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
  7. 5.3.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
  8. 5.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
  9. 5.3.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
  10. 5.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue
  2. 6.1.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2021-2026)
  3. 6.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Over the Counter (OTC) Drugs & Dietary Supplements Head Office and Area Served
  6. 6.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Players, Product Type & Application
  7. 6.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Established Date
  8. 6.6 Global Over the Counter (OTC) Drugs & Dietary Supplements Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  2. 7.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  4. 7.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  2. 8.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  4. 8.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  2. 9.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  2. 10.2 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  4. 10.4 South America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  2. 11.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Sanofi S.A
  2. 12.1.1 Sanofi S.A Company Information
  3. 12.1.2 Sanofi S.A Business Overview
  4. 12.1.3 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  5. 12.1.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  6. 12.1.5 Sanofi S.A Recent Developments
  7. 12.2 Johnson & Johnson
  8. 12.2.1 Johnson & Johnson Company Information
  9. 12.2.2 Johnson & Johnson Business Overview
  10. 12.2.3 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  11. 12.2.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  12. 12.2.5 Johnson & Johnson Recent Developments
  13. 12.3 Novartis International AG
  14. 12.3.1 Novartis International AG Company Information
  15. 12.3.2 Novartis International AG Business Overview
  16. 12.3.3 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  17. 12.3.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  18. 12.3.5 Novartis International AG Recent Developments
  19. 12.4 Merck & Co., Inc.
  20. 12.4.1 Merck & Co., Inc. Company Information
  21. 12.4.2 Merck & Co., Inc. Business Overview
  22. 12.4.3 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  23. 12.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  24. 12.4.5 Merck & Co., Inc. Recent Developments
  25. 12.5 Roche Holding AG
  26. 12.5.1 Roche Holding AG Company Information
  27. 12.5.2 Roche Holding AG Business Overview
  28. 12.5.3 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  29. 12.5.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  30. 12.5.5 Roche Holding AG Recent Developments
  31. 12.6 Pfizer Inc.
  32. 12.6.1 Pfizer Inc. Company Information
  33. 12.6.2 Pfizer Inc. Business Overview
  34. 12.6.3 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  35. 12.6.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  36. 12.6.5 Pfizer Inc. Recent Developments
  37. 12.7 GlaxoSmithKline plc.
  38. 12.7.1 GlaxoSmithKline plc. Company Information
  39. 12.7.2 GlaxoSmithKline plc. Business Overview
  40. 12.7.3 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  41. 12.7.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  42. 12.7.5 GlaxoSmithKline plc. Recent Developments
  43. 12.8 Bayer Healthcare AG
  44. 12.8.1 Bayer Healthcare AG Company Information
  45. 12.8.2 Bayer Healthcare AG Business Overview
  46. 12.8.3 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  47. 12.8.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  48. 12.8.5 Bayer Healthcare AG Recent Developments
  49. 12.9 AbbVie Inc.
  50. 12.9.1 AbbVie Inc. Company Information
  51. 12.9.2 AbbVie Inc. Business Overview
  52. 12.9.3 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  53. 12.9.4 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  54. 12.9.5 AbbVie Inc. Recent Developments
  55. 12.10 AstraZeneca plc.
  56. 12.10.1 AstraZeneca plc. Company Information
  57. 12.10.2 AstraZeneca plc. Business Overview
  58. 12.10.3 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  59. 12.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  60. 12.10.5 AstraZeneca plc. Recent Developments
  61. 12.11 The Colgate-Palmolive Company
  62. 12.11.1 The Colgate-Palmolive Company Company Information
  63. 12.11.2 The Colgate-Palmolive Company Business Overview
  64. 12.11.3 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  65. 12.11.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  66. 12.11.5 The Colgate-Palmolive Company Recent Developments
  67. 12.12 Reckitt Benckiser Plc.
  68. 12.12.1 Reckitt Benckiser Plc. Company Information
  69. 12.12.2 Reckitt Benckiser Plc. Business Overview
  70. 12.12.3 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  71. 12.12.4 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  72. 12.12.5 Reckitt Benckiser Plc. Recent Developments
  73. 12.13 Gilead Sciences
  74. 12.13.1 Gilead Sciences Company Information
  75. 12.13.2 Gilead Sciences Business Overview
  76. 12.13.3 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  77. 12.13.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  78. 12.13.5 Gilead Sciences Recent Developments
  79. 12.14 Bausch & Lomb
  80. 12.14.1 Bausch & Lomb Company Information
  81. 12.14.2 Bausch & Lomb Business Overview
  82. 12.14.3 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  83. 12.14.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  84. 12.14.5 Bausch & Lomb Recent Developments
  85. 12.15 Alliance Healthcare
  86. 12.15.1 Alliance Healthcare Company Information
  87. 12.15.2 Alliance Healthcare Business Overview
  88. 12.15.3 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  89. 12.15.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  90. 12.15.5 Alliance Healthcare Recent Developments
  91. 12.16 Allergan, Plc.
  92. 12.16.1 Allergan, Plc. Company Information
  93. 12.16.2 Allergan, Plc. Business Overview
  94. 12.16.3 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  95. 12.16.4 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  96. 12.16.5 Allergan, Plc. Recent Developments
  97. 12.17 Alkalon A/S
  98. 12.17.1 Alkalon A/S Company Information
  99. 12.17.2 Alkalon A/S Business Overview
  100. 12.17.3 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  101. 12.17.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  102. 12.17.5 Alkalon A/S Recent Developments
  103. 12.18 Alfresa Pharma Corporation
  104. 12.18.1 Alfresa Pharma Corporation Company Information
  105. 12.18.2 Alfresa Pharma Corporation Business Overview
  106. 12.18.3 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  107. 12.18.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  108. 12.18.5 Alfresa Pharma Corporation Recent Developments
  109. 12.19 Alcon Inc.
  110. 12.19.1 Alcon Inc. Company Information
  111. 12.19.2 Alcon Inc. Business Overview
  112. 12.19.3 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  113. 12.19.4 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  114. 12.19.5 Alcon Inc. Recent Developments
  115. 12.20 Alacer Corp.
  116. 12.20.1 Alacer Corp. Company Information
  117. 12.20.2 Alacer Corp. Business Overview
  118. 12.20.3 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2021-2026)
  119. 12.20.4 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  120. 12.20.5 Alacer Corp. Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst